Compare IDEXX Laboratories, Inc. (IDXX) vs Solaredge Technologies Inc (SEDG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Solaredge Technologies Inc — how do they compare? IDEXX Laboratories, Inc. trades at $551.53 (market cap $44.48B), while Solaredge Technologies Inc trades at $50.54 (market cap $2.96B). The key difference: IDEXX Laboratories, Inc. is far larger — about 15× Solaredge Technologies Inc's market cap, and Solaredge Technologies Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | SEDG | |
|---|---|---|
Market Cap | $44.48B | $2.96B |
Sector | Health | Technology |
52-Week High | $766.68 | $78.51 |
52-Week Low | $520.87 | $24.42 |
Enterprise Value | $45.38B | $2.89B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
SolarEdge Technologies (SEDG) trades at $48.65, down 9.01% in the last session, reflecting ongoing volatility. The stock shows a bearish technical signal with mixed earnings history—beating estimates in Q3 and Q4 2025 but missing in Q1 2026. Revenue declined to $1.18 billion in 2025, with a net loss of $405.45 million, though operating cash flow improved to $104.26 million. Analyst consensus is divided, with a hold-heavy rating and a $35.65 price target below the current price.
The outlook remains challenging due to persistent losses and competitive pressures, but potential catalysts include upcoming Q2 2026 earnings and demand for solar solutions. Key risks include high debt, margin pressures, and market sentiment shifts. Investors should weigh cost-cutting progress against sector headwinds for recovery potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Solaredge Technologies Inc
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →
